We report the case of a 31-year-old female in her 32nd week of pregnancy, who experienced an acute type A aortic dissection resulting in severe aortic insufficiency, dissection of the left anterior descending coronary artery, and left ventricular infarct with ejection fraction of 20%. After a successful cesarean section, she underwent a Bentall operation and three-vessel coronary artery bypass grafting. Despite maximal inotropic support, her cardiovascular indices deteriorated postoperatively. On the first postoperative day she was started on mechanical circulatory support with the Levitronix CentriMag left ventricular assist device. Her myocardial function improved and she was successfully weaned from this mechanical support on post-implant day 14. She remains alive and well to date.
Introduction
Despite pharmacological advances in postoperative cardiac surgical care and the use of intra-aortic balloon pumps (IABPs), the mortality due to post-cardiotomy cardiogenic shock remains high w1x.
In recent years, short-term mechanical circulatory support with a ventricular assist device (VAD) has been increasingly used as a bridge-to-decision in children and adults with hemodynamic failure due to various clinical etiologies including postcardiotomy cardiogenic shock w2x, deterioration of chronic cardiac failure w3x, septic shock w4x, and acute donor graft failure after heart transplantation w5, 6x.
Here, we report a successful application of the Levitronix CentriMag left VAD (Levitronix LLC, Waltham, MA, USA) as a bridge-to-recovery in a postcardiotomy patient with a refractory cardiogenic shock.
Case presentation
A 31-year-old woman with an unremarkable past medical history, who was 32 weeks' pregnant, was flown from district general hospital to our hospital 4 h after developing substernal chest pain radiating to her back and neck. Transesophageal echocardiogram (TEE) showed a type A dissecting aneurysm of the ascending aorta and signs of an acute myocardial infarction confirmed by electrocardiography. Her ejection fraction was 20%. She was transferred emergently to the operating room. Following a successful cesarean section, with uneventful course, repair of her type A aortic dissection was commenced via mid-sternotomy. Cardiopulmonary bypass was established via cannulation of the femoral artery, rather than the more frequently used right subclavian artery, due to the patient's profound hypotension and obese habitus. Both superior and inferior vena cavae were cannulated. Cardiac arrest was achieved by a combination of retrograde and selective antegrade cold blood cardioplegia with total volume 5000 ml. The patient underwent repair of the aortic dissection, which included hemiarch replacement using hypothermic circulatory arrest, with distal anastomosis proximal to the innominate artery, accompanied by a Bentall-DeBono procedure and triple coronary artery bypass grafting wSVG to left anterior descending (LAD), left marginal branch of circumflex artery (LM), right coronary artery (RCA)x. Aortic clamping time was 152 min while hypothermic circulatory arrest lasted 38 min. She was weaned from the cardiopulmonary bypass which lasted 221 min in sinus rhythm on moderate inotropic support. Her mean blood pressure was 70 mmHg, and she was transferred to the intensive care unit (ICU). At this time, her hemodynamic parameters and end-organ function were satisfactory. However, over the next 24 h, and despite ongoing maximum inotropic support, these parameters deteriorated ( Table 1) . We considered introducing an IABP, but believed it unwise because a TEE performed at that time revealed a dissection of the descending aorta. Therefore, 28 h after the initial procedure, Levitronix CentriMag VAD was introduced via a left atrial to ascending neo-aorta circuit, as described previously w7x. After a flow rate of 4700 mlymin was established, the patient was returned to ICU. She was anticoagulated with heparin (24,000 Uy24 h), with the partial prothrombin time maintained at 50 s. There were no thromboembolic or hemorrhagic events. She remained on Levitronix mechanical support for 14 days. During that time her hemodynamic indices and renal function improved significantly ( Table 1) . At the time of explantation of the VAD, echocardiographic assessment revealed an ejection fraction of 37%. There were no device-related infections and no technical complications.
The baby was a 1580 g, hypotrophic, male, who did well initially with Apgar scores of 6 and 7 at 1 and 5 min, respectively. Intubation and rescue surfactant application was necessary at 12 h of age. Blood pressure was supported with dopamine until the fourth day, no infection was present. The baby made an uneventful recovery, was extubated on day 7 and was discharged on day 34.
Discussion
Our previously healthy patient presented with a rare combination of a type A aortic dissection, multiple coronary artery insufficiencies including LAD dissection, and a large left ventricular infarct that lead to acute heart failure, all in a setting of advanced pregnancy. The patient's past medical history was unremarkable, however, there was an important family history of unspecified cardiac issues, suggesting a genetic predisposition for her presenting medical problems. The patient's multiple problems accounted for the complexity of her care throughout her stay in our hospital. Her large myocardial infarction and resulting cardiac failure made her unresponsive to inotropic support and the presence of a dissection in the descending aorta precluded introducing an IABP. In this scenario, we chose to use a VAD. We opted for Levitronix CentriMag mainly due to this device's reliability, its superior performance with regard to hemolysis, its decreased propensity for inducing a hypercoagulable state, and its ease of use. A review of the available literature revealed that in a minority of patients facing imminent death the use of CentriMag represents a bridge to recovery, with the majority of patients requiring either a heart transplant, long-term VAD support, or eventually succumbing to their deteriorating condition w4, 5, 7x. In our patient we consider the use of this device to have been life saving and, three and six months after explantation, both mother and child are alive and well, while echocardiographic assessment revealed an ejection fraction of 40%.
